Puneet Bagga1, Hari Hariharan1, Neil E Wilson1, Joanne C Beer2, Russell T Shinohara2,3, Mark A Elliott1, Joseph A Baur4, Francesco M Marincola5, Walter R Witschey1, Mohammad Haris1,6,7, John A Detre8, Ravinder Reddy1. 1. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Center for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Physiology and Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Refuge Biotechnologies Inc., Menlo Park, California. 6. Research Branch, Sidra Medical and Research Center, Doha, Qatar. 7. Laboratory Animal Research Center, Qatar University, Doha, Qatar. 8. Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
PURPOSE: Reliable monitoring of tissue nicotinamide adenine dinucleotide (NAD+ ) concentration may provide insights on its roles in normal and pathological aging. In the present study, we report a 1 H MRS pulse sequence for the in vivo, localized 1 H MRS detection of NAD+ from the human brain. METHODS: Studies were carried out on a 7T Siemens MRI scanner using a 32-channel product volume coil. The pulse sequence consisted of a spectrally selective low bandwidth E-BURP-1 90° pulse. PRESS localization was achieved using optimized Shinnar-Le Roux 180° pulses and overlapping gradients were used to minimize the TE. The reproducibility of NAD+ quantification was measured in 11 healthy volunteers. The association of cerebral NAD+ with age was assessed in 16 healthy subjects 26-78 years old. RESULTS: Spectra acquired from a voxel placed in subjects' occipital lobe consisted of downfield peaks from the H2 , H4 , and H6 protons of the nicotinamide moiety of NAD+ between 8.9-9.35 ppm. The mean ± SD within-session and between-session coefficients of variation were found to be 6.14 ± 2.03% and 6.09 ± 3.20%, respectively. In healthy volunteers, an age-dependent decline of the NAD+ levels in the brain was also observed (β = -1.24 μM/y, SE = 0.21, P < 0.001). CONCLUSION: We demonstrated the feasibility and robustness of a newly developed 1 H MRS technique to measure localized cerebral NAD+ at 7T MRI using a commercially available RF head coil. This technique may be further applied to detect and quantify NAD+ from different regions of the brain as well as from other tissues.
PURPOSE: Reliable monitoring of tissue nicotinamide adenine dinucleotide (NAD+ ) concentration may provide insights on its roles in normal and pathological aging. In the present study, we report a 1 H MRS pulse sequence for the in vivo, localized 1 H MRS detection of NAD+ from the human brain. METHODS: Studies were carried out on a 7T Siemens MRI scanner using a 32-channel product volume coil. The pulse sequence consisted of a spectrally selective low bandwidth E-BURP-1 90° pulse. PRESS localization was achieved using optimized Shinnar-Le Roux 180° pulses and overlapping gradients were used to minimize the TE. The reproducibility of NAD+ quantification was measured in 11 healthy volunteers. The association of cerebral NAD+ with age was assessed in 16 healthy subjects 26-78 years old. RESULTS: Spectra acquired from a voxel placed in subjects' occipital lobe consisted of downfield peaks from the H2 , H4 , and H6 protons of the nicotinamide moiety of NAD+ between 8.9-9.35 ppm. The mean ± SD within-session and between-session coefficients of variation were found to be 6.14 ± 2.03% and 6.09 ± 3.20%, respectively. In healthy volunteers, an age-dependent decline of the NAD+ levels in the brain was also observed (β = -1.24 μM/y, SE = 0.21, P < 0.001). CONCLUSION: We demonstrated the feasibility and robustness of a newly developed 1 H MRS technique to measure localized cerebral NAD+ at 7T MRI using a commercially available RF head coil. This technique may be further applied to detect and quantify NAD+ from different regions of the brain as well as from other tissues.
Authors: Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur Journal: Psychopharmacology (Berl) Date: 2011-05-21 Impact factor: 4.530
Authors: Xiaorong Liang; Lulu Yang; Ann R Qin; Justin Ly; Bianca M Liederer; Kirsten Messick; Shuguang Ma; Mark Zak; Peter S Dragovich; Brian J Dean; Cornelis E C A Hop; Yuzhong Deng Journal: Bioanalysis Date: 2014-06 Impact factor: 2.681
Authors: Natalia V Balashova; Lev G Zavileyskiy; Artem V Artiukhov; Leonid A Shaposhnikov; Olga P Sidorova; Vladimir I Tishkov; Angela Tramonti; Anastasia A Pometun; Victoria I Bunik Journal: Front Med (Lausanne) Date: 2022-05-19
Authors: Martyna Dziadosz; Maike Hoefemann; André Döring; Malgorzata Marjańska; Edward John Auerbach; Roland Kreis Journal: Magn Reson Med Date: 2022-05-08 Impact factor: 3.737